What Is the Starting Dose of Compounded Tirzepatide?

If you've just received your first vial of compounded tirzepatide, the most common thing I hear is a version of: “there's a syringe, a bottle, and a number on the label — what do I actually draw up?” That confusion is normal, and it's worth clearing up before your first injection.

Two things are true at once here. The dose in milligrams follows a well-established schedule used by the brand-name drugs. But the volume you draw into the syringe depends on how your particular pharmacy mixed that vial — and that number comes from your clinician, not from a chart you found online.

What compounded tirzepatide is — and how it differs from Mounjaro and Zepbound

Tirzepatide is the active ingredient in Mounjaro (approved for type 2 diabetes) and Zepbound (approved for weight management). It's a dual GIP and GLP-1 receptor agonist — it acts on two appetite and blood sugar pathways rather than one.

Compounded tirzepatide contains that same active ingredient, but it's prepared by a licensed compounding pharmacy for an individual patient with a valid prescription, rather than manufactured at scale by Eli Lilly and approved by the FDA. Same molecule, different oversight. Because it isn't FDA-approved, its quality depends on the pharmacy making it — which is why the pharmacy matters as much as the dose.

One practical difference matters for dosing: brand-name tirzepatide comes in a single-use auto-injector pen that delivers a fixed dose. Compounded tirzepatide usually comes as a multi-dose vial with syringes, which means the dose is something you measure. That's the entire reason the units question exists. You can read more about how our program handles it on the compounded tirzepatide page.

The standard starting dose: 2.5 mg once weekly

Almost everyone starts at 2.5 mg, injected subcutaneously once a week, on the same day each week. That holds whether you're on brand-name tirzepatide or a compounded version, because the starting dose is about your body adapting, not about which label is on the bottle.

I want to be direct about what this first month is for. 2.5 mg is a tolerability dose. Its job is to let your stomach and digestive tract adjust to GIP and GLP-1 activation gradually, so the jump to higher doses doesn't hit you like a wall. Some people feel appetite changes in the first week or two; plenty feel almost nothing. Both are normal, and neither predicts how you'll do at higher doses.

This is also the single most common reason people think their medication “isn't working.” It is working — it's doing the boring, important job of getting your body ready.

The usual titration schedule

From 2.5 mg, the dose typically steps up roughly every four weeks, as long as side effects are manageable. Six levels take you to the maximum of 15 mg weekly — about 20 weeks if you move at every step.

This is the standard schedule, not a prescription. Your clinician sets your actual dose and timing based on your history and how you respond.

Why your vial is measured in units, not milligrams

Here's where most of the confusion lives. A compounded vial contains tirzepatide dissolved in liquid at a specific concentration — something like 10 mg per mL, or 20 mg per mL, depending on the pharmacy. Your syringe, meanwhile, is marked in units. So the milligrams you need have to be translated into a volume you can actually draw.

The math is simple once you see it. With a U-100 syringe, 100 units equals 1 mL. If your vial is 10 mg/mL, then 1 mL contains 10 mg — so 2.5 mg is one quarter of a mL, which is 25 units. If your vial is 20 mg/mL, that same 2.5 mg is half the volume, about 12.5 units.

Notice what changed: the dose in milligrams stayed identical. The units did not. That is exactly why the units-per-mg conversion depends entirely on your pharmacy's concentration, and why a “tirzepatide dosing chart” from a stranger on the internet can be flat wrong for your vial.

How long to stay at each dose

The default is four weeks per step — long enough for the medication to reach a steady level in your body and for you to know how you tolerate it. But four weeks is a starting assumption, not a rule. You can stay longer, and that's often the smarter choice.

If you want the bigger picture of how the timeline usually unfolds — appetite first, scale later — our how it works walkthrough covers what happens week to week after you start.

What to do if you miss a dose

It happens — a busy week, a trip, a forgotten injection day. The general guidance for once-weekly tirzepatide is:

One more thing worth knowing: your dose and your injection day are usually written on your prescription label. If they ever disagree with what you remember being told, trust the label and confirm with your clinician.

Your dose is individual — and it has to be set by a clinician

I'll say the important part plainly: dosing is individualized, and it must be set by a licensed clinician after reviewing your health assessment. Tirzepatide is a prescription medication with real contraindications — a personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, pregnancy, and other conditions change the picture entirely. A schedule in an article can't weigh any of that.

What a good starting plan actually looks like: a clinician reviews your history, sets a starting dose and a titration plan, tells you the exact units for your specific vial, and stays reachable when something changes. If you have questions about eligibility, cost, or what's included, the frequently asked questions page covers the practical side in plain language.

Frequently asked questions